Chris Roane, Director in Bennett Thrasher’s Dispute Resolution & Forensics practice, recently co-authored an article for the American Health Law Association on the performance of IRO Arrangements Reviews as it relates to Corporate Integrity Agreements (CIA). Chris and fellow article author Jeffrey Wilson, SVP and General Counsel for Lexington Medical Center discussed the core requirements of CIAs and some tips for effectively navigating IRO Arrangements Reviews.
In January 2021, the U.S. Department of Justice (“DOJ”) reported its annual False Claims Act (“FCA”) statistics for recoveries resulting from civil settlements and judgements in fiscal year (“FY”) 2020 (October 1, 2019 – September 30, 2020). The FCA is the DOJ’s most powerful tool in combating false claims submitted to the government by individuals and companies. Most FCA cases brought by the government target those that operate in the healthcare industry.
It is no secret that healthcare regulatory compliance is front and center in the eyes of the United States Department of Justice (DOJ), the Department of Health and Human Services – Office of Inspector General (OIG) and the Centers for Medicare and Medicaid Services (CMS).
On March 27, 2017, the Department of Health and Human Services, Office of Inspector General (“OIG-HHS”), in collaboration with the Health Care Compliance Association (HCCA), published Measuring Compliance Program Effectiveness – A Resource Guide (the “Guide”).
Last week over 130 of the “who’s who” among attorneys focused on white collar crime from across the Southeast convened for the annual Southeastern White Collar Crime Institute, hosted by the American Bar Institute.